Literature DB >> 21274369

Delayed psychosis induced by bupropion in a former cocaine abuser: a case report.

Mohammad Farooque, Joshua Elliott.   

Abstract

Entities:  

Year:  2010        PMID： 21274369      PMCID： PMC3025990          DOI： 10.4088/PCC.09l00943gry

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  7 in total

1.  Bupropion-induced psychosis.

Authors:  W T Howard; J K Warnock
Journal:  Am J Psychiatry       Date:  1999-12       Impact factor: 18.112

2.  Acute psychosis following sustained release bupropion overdose.

Authors:  Tzong-Shi Wang; I-Shin Shiah; Chin-Bin Yeh; Chuan-Chia Chang
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-11-23       Impact factor: 5.067

3.  Psychosis induced by low-dose bupropion: sensitization of dopaminergic system by past cocaine abuse?

Authors:  Margaret Hahn; Tomas Hajek; Martin Alda; Jack M Gorman
Journal:  J Psychiatr Pract       Date:  2007-09       Impact factor: 1.325

4.  Prevalence of psychosis, delusions, and hallucinations in clinical trials with bupropion.

Authors:  J A Johnston; C G Lineberry; C S Frieden
Journal:  Am J Psychiatry       Date:  1986-09       Impact factor: 18.112

5.  Psychoses associated with bupropion treatment.

Authors:  R N Golden; S P James; M A Sherer; M V Rudorfer; D A Sack; W Z Potter
Journal:  Am J Psychiatry       Date:  1985-12       Impact factor: 18.112

6.  [Acute psychosis after administration of bupropion hydrochloride (Zyban)].

Authors:  Marcus Neumann; Vitali Livak; Hans-Werner Paul
Journal:  Psychiatr Prax       Date:  2004-11

7.  Acute psychosis after administration of bupropion hydrochloride (Zyban).

Authors:  M Neumann; V Livak; H-W Paul; G Laux
Journal:  Pharmacopsychiatry       Date:  2002-11       Impact factor: 5.788
  7 in total
  1 in total

Review 1.  Psychotic Symptoms Associated with the use of Dopaminergic Drugs, in Patients with Cocaine Dependence or Abuse.

Authors:  Carlos Roncero; Alfonso C Abad; Antonio Padilla-Mata; Elena Ros-Cucurull; Carmen Barral; Miquel Casas; Lara Grau-López
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.